机构：[1]Department of Epidemiology, Beijing An Zhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing 100029, China.首都医科大学附属安贞医院
Atherosclerosis is a chronic, progressive disease which eventually leads to coronary heart disease (CHD), ischemic stroke and other atherosclerotic cardiovascular disease (ASCVD). Numerous studies have demonstrated an atherogenic role of oxidized low-density lipoprotein (ox-LDL) in the progression of ASCVD. This article briefly reviews the atherogenic mechanism of ox-LDL, the methods of measuring ox-LDL in the circulation, effect of medical therapy and life-style modification on ox-LDL level, and the association between circulating ox-LDL and atherosclerosis, including clinical ASCVD events and subclinical atherosclerosis, in observational studies.
语种：
外文
PubmedID：
第一作者：
第一作者机构：[1]Department of Epidemiology, Beijing An Zhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing 100029, China.
推荐引用方式(GB/T 7714)：
Gao Shen,Liu Jing.Association between circulating oxidized low-density lipoprotein and atherosclerotic cardiovascular disease.[J].Chronic diseases and translational medicine.2017,3(2):89-94.doi:10.1016/j.cdtm.2017.02.008.
APA：
Gao Shen&Liu Jing.(2017).Association between circulating oxidized low-density lipoprotein and atherosclerotic cardiovascular disease..Chronic diseases and translational medicine,3,(2)
MLA：
Gao Shen,et al."Association between circulating oxidized low-density lipoprotein and atherosclerotic cardiovascular disease.".Chronic diseases and translational medicine 3..2(2017):89-94
